{"id":906279,"date":"2025-11-05T19:55:50","date_gmt":"2025-11-06T00:55:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/"},"modified":"2025-11-05T19:55:50","modified_gmt":"2025-11-06T00:55:50","slug":"praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/","title":{"rendered":"Praxis Precision Medicines to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BOSTON, Nov.  05, 2025  (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation inhibition imbalance, announced it will be attending and presenting at the following upcoming investor events:\u00a0<\/p>\n<ul type=\"square\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Truist Securities BioPharma Symposium:<\/strong> a corporate presentation will take place on Thursday, November 6, 2025, at 10:40am ET at the Lotte New York Palace Hotel in New York City.<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>HC Wainwright Emerging Ideas on BioPharma<\/strong>: Fireside Chat with H.C. Wainwright analyst Doug Tsao, Friday, November 7, 2025 at 12:30pm ET. Registration link available <a href=\"https:\/\/journey.ct.events\/view\/766d2250-9222-4095-909f-ef7d76e20031\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Guggenheim Securities Inaugural Healthcare Innovation Conference:<\/strong> a corporate presentation will take place on Monday, November 10, 2025, at 9:30am ET at the InterContinental Boston in Boston, MA. A live webcast of the presentation will be available <a href=\"https:\/\/event.summitcast.com\/view\/6h3HS7z68WnTQE5PS7Vq8J\/guest_book?session_id=WC6oRccigkWYBFumXgW9k2\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Jefferies Global Healthcare Conference: <\/strong>a corporate presentation will take place on Tuesday, November 18, 2025, at 1:30pm GMT at the Waldorf Hilton in London, UK. A live webcast of the presentation will be available <a href=\"https:\/\/wsw.com\/webcast\/jeff332\/register.aspx?conf=jeff332&amp;page=prax&amp;url=https:\/\/wsw.com\/webcast\/jeff332\/prax\/1865089\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<\/li>\n<\/ul>\n<p>Replays of the third quarter earnings webinar and the conference webcasts will be available on Praxis\u2019 \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HQUPU5x_DillvRXrCjO6WIBFbdpt2Y6zxfmmWe_xTrcSMXkuzXnQefUAEp1ldsqUdKCM6RQnv2gCLA8LSmp5Ze0cw2xbLrmnbO8qBTFKhn9_Z0Hx-sspQiHhfTleKhdkn3YVcyt2JHzGpu-zFvqZBAGKU8nAv3Scomhn5Q62u1M=\" rel=\"nofollow\" target=\"_blank\">Events and Presentations<\/a>\u201d website after each event for approximately 90 days.<\/p>\n<p>\n        <strong>About Praxis<\/strong><br \/>\n        <br \/>Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum\u2122, and antisense oligonucleotide (ASO) platform, Solidus\u2122, using our understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across epilepsy and movement disorders, with four clinical-stage product candidates. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fhnLgykSFlUwfD-7tMwa6fmY6SLTL7_e6XBYFELy0ueJQvYVWWp2nsgS2Jeujshb9Ffg2Q8vamYGtAddmJE8G0FFGhRlx9z0HdWBKNGyIotjAUMbhHdZvQs51idQ2FTlgGjLZLwIDb9jtP6RJvCUi-StvmFp31qMXZpVNJlC-4fAx1qEwe9lu1jEehTAu1JSPNIrzAkDHMHUGG6iMkNfv2debv4RvOgp2GpG037YHxe4mCKsUUp7E16etN1dqL27Li1VaF2BQYjAM3AUDL-AtlP6iSEIsY3gnfJZc1dgZJ_gFgp78LyDb0WLfwSGlkMSc_qNdqZ1QXj7H2Ea6-nW6jdEHzdejTeG6yqNKPcVnETne5wBwYjpYsR13aTqnJxjki3ZIauqc7HnMShZLDc69mgWG5_LBBeFqfjNy7wG1Bv8Y2GQ_3K_zK-uY8JFoZ7u--aOxm3R4lOyNcfHOqbpZ3-rKVVaWtZZS58HWol1Jkv3KMNzzY8v_28ZH8T1bqqWBpmGC29a7uAbuvThrhPeqQzTcg84JRAPXLuDrn8LeSDSHcj-AsTHnTv1EHkckitg26l8jbk7vliK8KaqfaR0kk5iTbTrvpFkzmGjN-yI5ED8qUMl5hv3X1cZ1NwWm8C9gDQCCYsuDJWhQTPBtqUmc_a8YU4NlKM6vCdPwTZZ8DAoBIqClPYCglNTjZ1Dw8OKN4HYXPtAdDMks0Frj4mCWWlfzCL3jGWgSnVdbNFMkoe6y6_878v3h_FuIDRTvAX4g4Am5dzG0dGHm5YUYJXhMg94AUU2Aj-AHbK9feewAv4=\" rel=\"nofollow\" target=\"_blank\">www.praxismedicines.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=T3ISeBaSbBbd59W8jm90iocRmdm7ut5RzBK_ge0tzW6McrPLLAFzKmtUZuWK7JF5C5MmGJ2zZZSNbe6BbDkktU2RlOZ4clQC4iuvkBXvFEALGv-K1xbpCs_MpVbVVq8k7EKY50n4wisDoM3_DFnvuebZx49T_yzsQmRiMjJVb2fsu5cH7gaHkp2gX2Wvl6nQG14fzeFEGwMb_RDDEza4fbvBDwuHS3ZNxYlRLKVRLr1dVfDcQw91Hx2VTa1XXtZ55eFTYRWncqYs4j4g01Dq7c17LEW8xA1fERdqXBMYSpo5pCZPEeB9H79sgXEZl_eD5SJchwWx0K1iYeSgkrc1K0Cz9JMHBP6Kxjl03KaY19Co5gcML73wgF_58WZ6N2REy1rH5B1U-GCaORC-Vwuk45TpM1j9KFO9OU6HhGKdDQTiLIo4G9Zkkj8HrCXJ5wGsgD1IT9qNJFYP_cwkyuiPxk_JbwiJk9_SDYY2LEsTTB3FbhpbBHD6X7ZCXupQhCvLhYQEpEnYBExiPNOs8zhAxYH6vEa5tDKb3wILV4sPPxDho1DiG83RYfqGIFBKpcgZtISU3cSxFMt1AUT-JWLsGjj5bhFb8FZwpqpNi-qRZM20md0WijOFzII2HbwuO1mqTziXy4riqKR2F-A6qvIOVnACFM4cEZy5uXIe_n3T3aj_Zf3cas5Lpe9dXqZqRm4ckLrD4zrUTarUl9CM14UcRY3l7Y--yPaKLMUNXXzHR88odkdBWLidleHd8PUmQtf7\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XVOAa1PkyYSSYKQf5qdA67BAyRz_imgeiASlVTwslLiApYYhqoZuM7FVnFBv1hSZhTLckrgcrxpASUSbAYVYgRovNVbJhIyETlwTjaPe0oW3sP0r6xwMWJrXOGv6n3jea2ZQpTh1UrhE4faHrszrfyT9-sL9FOE0AOhgzLzgU84i2uOGJ_4P2jUFMJlluYfKzjlnO7fGHZLn9WtK6JQCllc43UOT_e8rnajl1NS9iuH605FTV7dr-FOBrmLlJ69XbGwbESoo00UKSLLewMP-xB0aCaiYfI5bPGBDjYJbj6-1II4MkbVX0f7yH21aUdiGYAkVt2CXJrHRRFjnRLZJoz64Ql8txz2UdLbxZvZjWU_aeSg9qIAlAJCDT91ocKJDKILjDay473jdwqxdRF88xnuEKLVJKN-9kAKDWF2Vx_bxN41-OWhIpAcevroiaf-J\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TdPvr4FCQ8E0XBJt_6i6NPYMwd0Xf1ASNyV8wbZpvD3kql73zZxuYp1FrOY6fqls2dzHXAoygKjDaf8rVrc9R64RMjGng0AbNsK_oEJ4mys2pwEPrhD8ns3MTjuRiafMMIPIhfbCyafX01sdZsDT09pIj0WBrF4H9UCanW-9K6YuYqJNGQLkchOpBydKA0Rk71wtLKmpDNiBT0WIScPZ4HwCP7RI7y5G9h1CUUSSNOaKy35xMcHHH9CG26ablqojf_xi8d63Q0dHF8ESeLXZY-deLeKqLwyIfTPH9cmZrylVV0AwLUdW6QpF5HRjYOPApB5PFKYuOFBO2bnQ5L8jCIN-CNuAUvhyF9pejBiUy_Q4jQUU2Kd3Nj6CnttjFKritCjKUzcIMzfASb6gBbcRPsFdlAW7Qe53-TEAjOAeZQf1D5VSgPGH41k1bOmkAVPk06aijx4yq0K24WSSCfOI65BmAS6d6xpk8PSB6515i3JFnqeyJ42V3BVNXtOlh_F46qBkipBpGzCmSq3BHwH3DFsXpg3z0rs5L_ysgj5H6vJZcbRmyg9Qyp_hqAb0vBIVjHg1eL697yQVo6n8pj9Z3_9Coql08ad_G7kpfWNUUgneET6wG6Itor4mo7LpJuVnOCHoBW17xsbVlet88j3irc_BINfL0hkruqcmYn6Hy6WL5kif8SG61SoqiYSCrgTsfKd1XHtfwid1JJiuRzmcVdyN-1hCxj-L4XclLbA6KZ5ji5weSleF-JAFjVx-WGfqsnJASbeNTJ2MUzs07eF2_d5DVcsQ7FlVsxUEjgt90BhR7YtfWla2QwEvm2iWc5XI\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YoUe56XZLp91dO-F1t4yLGPvjTRnPJ3bMjw_gYQ66A2xWftdgyXJ0S35dFLEfnacIZcVRoo00zN10vlWq5YX9uK7pZWZ_3jE8RT23Rxfr8IJiHarTx-BgnKPkaMx856HJwoHSjFD64FYRnNiWSRKQKlDnXnSUWt61cd2MOS7sUgC2-jbp39lhpMmx_r0p7ikQKf0FaR1_Dew1JyhxoW6K3nxrKsHZfGl056u3CbdicXUpHet3fK0d2V-IWqsLbnw3MFs-5uto_k7jiBpnDZ4FpJPt7gobnecDh2hY0nl4YLFSziPuugrsakyAJ424G4nOWFm-nxoPNgyPn5p4Qid7HU6SPXY7pRmx48q1XYK9tuJ0fXT0VzHaEnfXrkHjMx1nNWwpXNpOLrED-_Py7X18A6maR3yCRFJvf6D4J8gIXSFFNOqoGgWPIm_Njmi8fRonqTiEh9j9mspqJg0yUVYzpo1nr6AQAhqDU06wE6BBofuvaqceOO-IIs5aTw16rGkANh4ME3hb1ElOGAhFeMSqgR01prlUv6Hyro9fB7IFJV8h_kJJavZAaa0mBlSMQHcjKqoArt2rq1nvkWQ0g6JdZy_47eGJl1tXepsHBUIa2cICcdfKjY_V6_JvKcOdebs2dAIRIzoQR4xgvnfD5s1jlb7WcofxC5ZXQXrOUGoEujM2K5cqf35CaLarPGNFCBG6NkiQzuMYq-qamX1TEbveDPjeyNVTdXQPRDC-k1Wq8g=\" rel=\"nofollow\" target=\"_blank\">Twitter\/X<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTYzMSM3MjQ2NjMyIzIyMDA4OTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Zjg0M2FlMDQtZDQzMy00NzE3LWE5MWUtZDFhOGIwNDJhN2U4LTEyMTI0NDktMjAyNS0xMS0wNS1lbg==\/tiny\/Praxis-Precision-Medicines-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investor Contact:\r\nPraxis Precision Medicines\r\ninvestors@praxismedicines.com\r\n857-702-9452\r\n\r\nMedia Contact:\r\nDan Ferry\r\nLife Science Advisors\r\nDaniel@lifesciadvisors.com\r\n617-430-7576<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation inhibition imbalance, announced it will be attending and presenting at the following upcoming investor events:\u00a0 Truist Securities BioPharma Symposium: a corporate presentation will take place on Thursday, November 6, 2025, at 10:40am ET at the Lotte New York Palace Hotel in New York City. HC Wainwright Emerging Ideas on BioPharma: Fireside Chat with H.C. Wainwright analyst Doug Tsao, Friday, November 7, 2025 at 12:30pm ET. Registration link available here. Guggenheim Securities Inaugural Healthcare Innovation Conference: a corporate presentation will take place on Monday, November 10, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Praxis Precision Medicines to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-906279","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Praxis Precision Medicines to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Praxis Precision Medicines to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation inhibition imbalance, announced it will be attending and presenting at the following upcoming investor events:\u00a0 Truist Securities BioPharma Symposium: a corporate presentation will take place on Thursday, November 6, 2025, at 10:40am ET at the Lotte New York Palace Hotel in New York City. HC Wainwright Emerging Ideas on BioPharma: Fireside Chat with H.C. Wainwright analyst Doug Tsao, Friday, November 7, 2025 at 12:30pm ET. Registration link available here. Guggenheim Securities Inaugural Healthcare Innovation Conference: a corporate presentation will take place on Monday, November 10, &hellip; Continue reading &quot;Praxis Precision Medicines to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-06T00:55:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTYzMSM3MjQ2NjMyIzIyMDA4OTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Praxis Precision Medicines to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2025-11-06T00:55:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"wordCount\":313,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2OTYzMSM3MjQ2NjMyIzIyMDA4OTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\\\/\",\"name\":\"Praxis Precision Medicines to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2OTYzMSM3MjQ2NjMyIzIyMDA4OTY=\",\"datePublished\":\"2025-11-06T00:55:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2OTYzMSM3MjQ2NjMyIzIyMDA4OTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2OTYzMSM3MjQ2NjMyIzIyMDA4OTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Praxis Precision Medicines to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Praxis Precision Medicines to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"Praxis Precision Medicines to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation inhibition imbalance, announced it will be attending and presenting at the following upcoming investor events:\u00a0 Truist Securities BioPharma Symposium: a corporate presentation will take place on Thursday, November 6, 2025, at 10:40am ET at the Lotte New York Palace Hotel in New York City. HC Wainwright Emerging Ideas on BioPharma: Fireside Chat with H.C. Wainwright analyst Doug Tsao, Friday, November 7, 2025 at 12:30pm ET. Registration link available here. Guggenheim Securities Inaugural Healthcare Innovation Conference: a corporate presentation will take place on Monday, November 10, &hellip; Continue reading \"Praxis Precision Medicines to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-06T00:55:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTYzMSM3MjQ2NjMyIzIyMDA4OTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Praxis Precision Medicines to Participate in Upcoming Investor Conferences","datePublished":"2025-11-06T00:55:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/"},"wordCount":313,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTYzMSM3MjQ2NjMyIzIyMDA4OTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/","name":"Praxis Precision Medicines to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTYzMSM3MjQ2NjMyIzIyMDA4OTY=","datePublished":"2025-11-06T00:55:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTYzMSM3MjQ2NjMyIzIyMDA4OTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTYzMSM3MjQ2NjMyIzIyMDA4OTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Praxis Precision Medicines to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/906279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=906279"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/906279\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=906279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=906279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=906279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}